ELISA ANALYZER MARKET ANALYSIS

ELISA Analyzer Market by Mode of Action (Automated (1 Plate, 2 Plate and 4 Plate) and Semi-Automated), by Modality (Bench-Top and Stand-Alone), by Application (Vaccines Development, Immunology, Diagnosis, Toxicology, Drug Monitoring and Pharmaceutical Industry, Others), by End Users (Clinical Research Organizations, Pharmaceutical and Biotechnology Companies, Educational and Research Institutes, Diagnostic Laboratories, and Others) and by Region - Size, Share, Outlook and Opportunity Analysis, 2022-2028

Key Development

In August 2019, PerkinElmer, Inc., launched EUROIMMUN Aspergillus Antigen ELISA for detection of aspergillus infections.
In 2017, Siemens Healthineers, received CE mark for Atellica Solution, which is an automated immunoassay and chemistry analyzer and are available in the U.S., Europe, South America, and Asian markets.
In 2014, Sysmex Corporation launched HISCL-800, a compact and automated immunoassay system used for the immunochemistry testing.
In 2012, Dynex Technologies Inc., received china state food and drug administration (SFDA) approval for its DS2 automated enzyme-linked immunosorbent assay (ELISA) analyzer in China. This DS2 assay is considered to be an automated ELISA processing system for clinical diagnostic assays.
In 2012, Gold Standard Diagnostics, Corp. (GSD) launched fully automated ELISA platform thunderbolt